UCB leadership discusses how bridging regulatory approval and real-world access requires integrated care coordination and a long-term commitment to the patient journey.
Brad Chapman
Advertisement
Brad Chapman is the head of US Epilepsy and Rare Syndromes at UCB.
Articles by Brad Chapman
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
AAP updates guidance on pediatric iron deficiency screening and treatment
2
Pediatric clinical trial update: Q2 2026
3
FDA expands roflumilast cream approval to children as young as 2 years with plaque psoriasis
4
5 FDA decisions to watch for during 2H 2026
5